Now needed: Genomic medicine strategies

Since 2001, when the first draft of the Human Genome Project was announced, hope surged for genomic medicine to be a panacea for many health conditions from diagnosis to treatment. Soon after the project was complete in 2003, the early tangible examples of success did not match the high expectations of that time. But today, there is renewed confidence in the healthcare and life sciences industries that the hype could indeed match the hope.

Register to download the executive report

Study highlights

In three to five years, an individual who interacts with healthcare system will likely have a genome-based eletronic record or “genomic health record.” -

Sequencing capability will increasingly happen in a cloud-based environment enabling the aggregation and analysis of multiple sources of genomic data. -

Opportunity rests in leveraging cognitive computing throughout the entire value chain - from pre-clinical discovery to engaging consumers and improving health outcomes. -

About the authors

Aditya Pai

Aditya Pai
Associate Partner, IBM Watson Health,
Healthcare and Life Sciences

Takahiko Koyama

Takahiko Koyama
Lead Scientist - Watson Genomics
IBM Research

Heather Fraser

Heather Fraser
IBM Institute for Business Value,
Global Life Sciences and Healthcare Lead

Read related IBM executive reports

Precision health and wellness

The next step for population health management

Analytics across the ecosystem

A prescription for optimizing healthcare outcomes

Collaborating beyond traditional boundaries

What convergence means for our health care systems

Download the IBV App

Access our latest thought leadership, including C-suite studies and industry insights. Maintain a library, receive regular updates. Explore enhanced content.

Subscribe to the IdeaWatch Newsletter

Sign up to receive monthly e-mail updates on recent papers from the IBM Institute for Business Value.

IBM Healthcare

Transform your organization’s value with access to new and unprecedented amounts of data - across populations and at the level of the individual - for deeper insight, personalization and earlier interventions.